AI analyzes Reddit posts to find underreported GLP-1 side effects

The Rise of ‘Computational Social Listening’: How AI is Uncovering Hidden Drug Side Effects For decades, identifying drug side effects relied heavily on clinical trials and post-market reporting. Now, a new approach is gaining traction: analyzing the vast ocean of patient experiences shared on social media. Researchers at the University of Pennsylvania have pioneered a … Read more

Scientists Discover Genetic Cause of Diabetes in Newborns

Unlocking the Secrets of Baby Diabetes: A New Era in Genetic Understanding Imagine the shock of a diabetes diagnosis in a newborn. Neonatal diabetes, a rare condition appearing within the first six months of life, isn’t linked to lifestyle factors but to subtle alterations in a baby’s genetic code. Recent breakthroughs from the University of … Read more

High-quality plant-based diets linked to lower dementia risk

Plant-Based Diets and Alzheimer’s: Quality Matters, New Research Shows A new study published in Neurology®, the medical journal of the American Academy of Neurology, reveals a significant link between plant-based diets and the risk of Alzheimer’s disease and related dementias. Still, the research emphasizes that simply *eating* plant-based isn’t enough – the quality of the … Read more

Early genetic signals connect diabetes subgroups to heart disease risk

Predicting Heart Disease Risk in Diabetes: A New Genetic Approach Researchers at Lund University in Sweden are making strides in predicting coronary heart disease risk in individuals with diabetes. A growing body of research confirms that diabetes isn’t a single condition, but can be categorized into five distinct subgroups. This new understanding is paving the … Read more

Evolocumab reduces cardiac events in high-risk diabetic patients

Evolocumab: A New Era in Proactive Heart Disease Prevention? A groundbreaking analysis from the VESALIUS-CV trial, presented at the American College of Cardiology’s Annual Scientific Session, suggests a potential shift in how we approach heart disease prevention. The study reveals that evolocumab, a PCSK9 inhibitor, significantly reduced the risk of major cardiovascular events – by … Read more

A healthy pregnancy doesn’t depend solely on the woman: why the father’s health is crucial for child development | Health

Beyond the Bump: Why a Father’s Health is Now Center Stage in Prenatal Care For decades, prenatal care has rightly focused on the mother-to-be – her diet, lifestyle, and overall health. But a growing body of research, culminating in a multidisciplinary review published in The Lancet, is turning that paradigm on its head. The health … Read more

Korean Researchers Develop Flexible Neural Stimulator for Chronic Disease Treatment

Revolutionary ‘Soft’ Neural Stimulator Offers New Hope for Chronic Disease Treatment A South Korean research team at the Pohang University of Science and Technology (POSTECH) has unveiled a groundbreaking neural stimulator designed to overcome a key challenge in neuromodulation therapy: the demand for both rigidity during insertion and flexibility once implanted. This innovation promises to … Read more

Breast reduction surgery is linked to lower diabetes and heart risk

Beyond Aesthetics: Could Breast Reduction Be a Metabolic Game Changer? For decades, breast reduction surgery has been recognized for its ability to alleviate physical discomfort and improve quality of life. But emerging research suggests this procedure may offer benefits that extend far beyond the cosmetic – potentially impacting long-term metabolic health. A recent study analyzing … Read more

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study

GLP-1s: A Recent Chapter in Type 1 Diabetes Management? A groundbreaking analysis suggests glucagon-like peptide-1 receptor agonists (GLP-1RAs) – already well-established in type 2 diabetes treatment – could offer significant benefits for individuals living with type 1 diabetes (T1D). The research, published in Nature Medicine, points to reduced risks of cardiovascular events and kidney disease … Read more

Ozempic Goes Generic —But Not in the US

Ozempic’s Patent Cliff: A Global Shift in Diabetes and Weight Loss Treatment A pivotal moment is unfolding in the pharmaceutical landscape as patent protections for semaglutide – the active ingredient in both Ozempic (for diabetes) and Wegovy (for weight loss) – expire in key global markets. This expiration, beginning Saturday, March 28, 2026, is poised … Read more